BTCY: Biotricity, Inc. - Summary | Jitta

Biotricity, Inc.

NASDAQ:BTCY

Notice
Stock data is unavailable or the company’s delisted.
Price
$0.44
Loss Chance
49.4%
4.56JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (70)
Recent Business Performance (75)
Financial Strength (32)
Return to Shareholders (20)
Competitive Advantage (66)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
SG&A to SalesDecreasing Every Year
Cash Conversion CycleLess than 30 days
Revenue and EarningEarning loss detected in 2024
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
4.56
100.00%
3.06
148.42%
Health Care Technology
5.26
26.47%
4.60
28.36%
6.67
45.23%
COMPANY DESCRIPTION
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. Biotricity, Inc. is based in Redwood City, California.